Identifies themes and clusters of stock movements
Market TodayThemes and Stocks SummaryThematic Stock SearchClick here for daily refresh schedule
BASI - Bioanalytical Systems Inc.
$15.60
0.20(1.30%)9:00:00 PM 1/15/2021
Bioanalytical Systems, Inc., doing business as Inotiv, a pharmaceutical development company, provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment also provides in vivo sampling services for the continuous monitoring of chemical changes in life; non-clinical toxicology and pathology services; analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.
Stock Chart

Summary:

  • RSI is at a high level of 86. A high level of RSI indicates the stock is overbought.
  • MACD is crossing MACD signal line at 0.3. MACD crossing signal line is bullish signal.

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Related Topics
leak data

Related Topics

Peers

Stock news

    01/11/2021BASI
    Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical Models

    Daniel Smeak, DVM, ACVS Daniel Smeak, DVM, ACVS, Joins Inotiv as Vice President, Surgical ModelsWEST LAFAYETTE, Ind., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that Daniel Smeak, DVM, ACVS, has joined the Company as Vice President, Surgical Models, effective December 30, 2020. Dr. Smeak is based...

    01/3/2021BASI
    What You Need To Know About Bioanalytical Systems, Inc.'s (NASDAQ:BASI) Investor Composition

    A look at the shareholders of Bioanalytical Systems, Inc. ( NASDAQ:BASI ) can tell us which group is most powerful...

    12/22/2020BASI
    The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes

    Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 20) * Acceleron Pharma Inc (NASDAQ: XLRN) * Adaptive Biotechnologies Corp (NASDAQ: ADPT) * Allakos Inc (NASDAQ: ALLK) * Alpine Immune Sciences Inc (NASDAQ: ALPN) * AtriCure Inc. (NASDAQ: ATRC) * Beam Therapeutics Inc (NASDAQ: BEAM) * BioNTech SE - ADR (NASDAQ: BNTX) (the company's coronavirus vaccine candidate received positive recommendation from...

    12/21/2020BASI
    BASi Releases Earnings for Fourth Quarter of Fiscal 2020

    WEST LAFAYETTE, Ind., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three and twelve months ended September 30, 2020. FY 2020 Highlights * Revenue increased 38.6% to $60.5 million, from $43.6 million for the twelve months ended September 30, 2019 (“FY 2019”), driven by $5....

    12/18/2020BASI
    BASi to Release Earnings for Fourth Quarter of Fiscal 2020 on Monday, December 21, 2020

    WEST LAFAYETTE, Ind., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that it will report financial results for the three and twelve months ended September 30, 2020, prior to market opening on Monday, December 21, 2020. If there are any questions after the press release is issued, please direct your co...

    10/20/2020BASI
    Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, Pharmacology and Toxicology Operations

    WEST LAFAYETTE, Ind., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“Inotiv”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of drug discovery and development services, announced today that Andrew N. Alexander, DVM, Ph.D., MBA, DABT, has joined the Company as Vice President, Pharmacology and Toxicology Operations, effective October 19, 2020. "Andy brings a skillset that will help us grow Inotiv by providing broader expertise to ou...

    09/9/2020BASI
    BASi to Participate in H.C. Wainright Investment Conference

    WEST LAFAYETTE, Ind., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that it will participate in the H.C. Wainright 22nd Annual Global Investment Conference. The Company will present on Wednesday, September 16th, at 2:30 p.m. EDT. A live webcast of the presentation will be available through a link that will b...

    08/21/2020BASI
    Is Bioanalytical Systems' (NASDAQ:BASI) 195% Share Price Increase Well Justified?

    The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...

    08/14/2020BASI
    BASi Releases Earnings for Third Quarter of Fiscal 2020

    WEST LAFAYETTE, Ind., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi”, the “Company”, “We” or “Our”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced financial results for the three months ended June 30, 2020.During the third quarter of fiscal 2020, the Company saw 45.2% revenue growth compared to the third quarter of fiscal 2019. Growth initiatives including acquisitions of the Gaithersbur...